Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature A Oliva, G Siccardi, A Migliarini, F Cancelli, M Carnevalini, M D’Andria, ... Infection 48, 871-877, 2020 | 64 | 2020 |
Low-grade endotoxemia and thrombosis in COVID-19 A Oliva, V Cammisotto, R Cangemi, D Ferro, MC Miele, M De Angelis, ... Clinical and translational gastroenterology 12 (6), e00348, 2021 | 48 | 2021 |
Determinants of prolonged viral RNA shedding in hospitalized patients with SARS-CoV-2 infection FC Dezza, A Oliva, F Cancelli, G Savelloni, S Valeri, V Mauro, ... Diagnostic microbiology and infectious disease 100 (2), 115347, 2021 | 46 | 2021 |
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem … A Oliva, L Scorzolini, A Cipolla, MT Mascellino, F Cancelli, D Castaldi, ... Journal of Antimicrobial Chemotherapy 72 (7), 1981-1984, 2017 | 44 | 2017 |
Efficacy of two micro-gravitational protocols to treat chronic low back pain associated with discal lesions: a randomized controlled trial R Saggini, F Cancelli, V Di Bonaventura, RG Bellomo European Journal of Physical and Rehabilitation Medicine 40 (4), 311, 2004 | 34 | 2004 |
Role of Double‐Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem‐Resistant Enterobacteriaceae: A Single … F Cancelli, A Oliva, M De Angelis, MT Mascellino, CM Mastroianni, ... BioMed Research International 2018 (1), 2785696, 2018 | 27 | 2018 |
Role of serum E-selectin as a biomarker of infection severity in coronavirus disease 2019 A Oliva, E Rando, D Al Ismail, M De Angelis, F Cancelli, MC Miele, ... Journal of Clinical Medicine 10 (17), 4018, 2021 | 21 | 2021 |
Effect of N-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant Klebsiella pneumoniae and … A Oliva, A Bianchi, A Russo, G Ceccarelli, F Cancelli, F Aloj, ... Antibiotics 10 (3), 271, 2021 | 21 | 2021 |
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and … A Oliva, F Cancelli, A Brogi, A Curtolo, G Savelloni, G Siccardi, G Marcelli, ... New Microbiologica 45 (1), 62-72, 2022 | 13 | 2022 |
Prognostic Value of 12-Leads Electrocardiogram at Emergency Department in Hospitalized Patients with Coronavirus Disease-19 G Savelloni, MC Gatto, F Cancelli, A Barbetti, F Cogliati Dezza, C Franchi, ... Journal of Clinical Medicine 11 (9), 2537, 2022 | 11 | 2022 |
Clinical course of Coronavirus Disease-19 in patients with haematological malignancies is characterized by a longer time to respiratory deterioration compared to non … A Oliva, A Curtolo, L Volpicelli, F Cancelli, C Borrazzo, F Cogliati Dezza, ... Infection 50 (5), 1373-1382, 2022 | 10* | 2022 |
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: analysis of cases and evaluation of in vitro activity of fosfomycin-containing … A Oliva, D Al Ismail, G Arcari, MC Miele, E Casali, F Sacco, L Volpicelli, ... Journal of Global Antimicrobial Resistance 33, 321-327, 2023 | 9 | 2023 |
Real-life use of remdesivir-containing regimens in COVID-19: a retrospective case-control study FC Dezza, A Oliva, V Mauro, FE Romani, R Aronica, G Savelloni, E Casali, ... Le Infezioni in Medicina 30 (2), 211, 2022 | 9 | 2022 |
Composition of the essential oil of Coristospermum cuneifolium and antimicrobial activity evaluation A Venditti, C Frezza, G Salutari, M di Cecco, G Ciaschetti, A Oliva, ... Planta Medica International Open 4 (02), e74-e81, 2017 | 8 | 2017 |
CURB-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia A Oliva, C Borrazzo, MT Mascellino, A Curtolo, D Al Ismail, F Cancelli, ... Le Infezioni in Medicina 29 (3), 408, 2021 | 5 | 2021 |
Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients L Loffredo, P Pignatelli, M Pirro, G Ceccarelli, A Oliva, E Maggio, ... Internal and Emergency Medicine 18 (3), 889-895, 2023 | 4 | 2023 |
Clinical characteristics and risk factors for mortality in COVID-19 patients during the first wave of the COVID-19 pandemic in Rome, Italy: a single-center retrospective study E Rando, A Oliva, F Cancelli, C D’Agostino, G Savelloni, MR Ciardi, ... Le Infezioni in Medicina 31 (1), 49, 2023 | 4 | 2023 |
Real-life experience in the use of ceftobiprole for the treatment of nosocomial pneumonia: a case series A Oliva, G Savellon, F Cancelli, S Valeri, V Mauro, R Aronica, F Romani, ... Journal of Global Antimicrobial Resistance 26, 52-54, 2021 | 4 | 2021 |
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study A Oliva, F Cogliati Dezza, F Petrucci, FE Romani, M Morviducci, ... Clinical and Experimental Medicine 23 (6), 2275-2285, 2023 | 3 | 2023 |
Real-world use of imipenem/cilastatin/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa … C Leanza, MT Mascellino, L Volpicelli, S Covino, A Falletta, F Cancelli, ... Frontiers in Microbiology 15, 1432296, 2024 | 1 | 2024 |